Clinical Trials Browser

Phase 3 × Decitabine × Tumor-Agnostic × Clear all

NCT04292769 2020-03-03

Clinical Study of DC-CIK Cells as a Post-remission Treatment for Malignant Tumors

Phase 3 Unknown

Neoplasms